- Home
- STRO vs HOND Comparison
STRO vs HOND Comparison
Compare STRO & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- HOND
- Stock Information
- Founded
- STRO 2003
- HOND 2024
- Country
- STRO United States
- HOND United States
- Employees
- STRO N/A
- HOND N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- HOND
- Sector
- STRO Health Care
- HOND
- Exchange
- STRO Nasdaq
- HOND NYSE
- Market Cap
- STRO 172.8M
- HOND 287.8M
- IPO Year
- STRO 2018
- HOND 2024
- Fundamental
- Price
- STRO $1.97
- HOND $10.01
- Analyst Decision
- STRO Strong Buy
- HOND
- Analyst Count
- STRO 7
- HOND 0
- Target Price
- STRO $12.14
- HOND N/A
- AVG Volume (30 Days)
- STRO 1.4M
- HOND 1.1K
- Earning Date
- STRO 11-13-2024
- HOND 01-01-0001
- Dividend Yield
- STRO N/A
- HOND N/A
- EPS Growth
- STRO N/A
- HOND N/A
- EPS
- STRO N/A
- HOND N/A
- Revenue
- STRO $160,955,000.00
- HOND N/A
- Revenue This Year
- STRO N/A
- HOND N/A
- Revenue Next Year
- STRO N/A
- HOND N/A
- P/E Ratio
- STRO N/A
- HOND N/A
- Revenue Growth
- STRO 230.90
- HOND N/A
- 52 Week Low
- STRO $1.70
- HOND $9.97
- 52 Week High
- STRO $6.13
- HOND $11.57
- Technical
- Relative Strength Index (RSI)
- STRO 31.89
- HOND N/A
- Support Level
- STRO $1.70
- HOND N/A
- Resistance Level
- STRO $3.01
- HOND N/A
- Average True Range (ATR)
- STRO 0.20
- HOND 0.00
- MACD
- STRO -0.01
- HOND 0.00
- Stochastic Oscillator
- STRO 20.61
- HOND 0.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.